Advantage Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $74K | Sell |
759
-334
| -31% | -$32.6K | 0.06% | 276 |
|
|
2019
Q2 | $143K | Buy |
1,093
+18
| +2% | +$2.36K | 0.11% | 185 |
|
|
2019
Q1 | $145K | Sell |
1,075
-67
| -6% | -$9.04K | 0.11% | 184 |
|
|
2018
Q4 | $111K | Sell |
1,142
-73
| -6% | -$7.1K | 0.08% | 217 |
|
|
2018
Q3 | $169K | Buy |
1,215
+354
| +41% | +$49.2K | 0.11% | 156 |
|
|
2018
Q2 | $107K | Hold |
861
| – | – | 0.08% | 240 |
|
|
2018
Q1 | $96K | Buy |
861
+286
| +50% | +$31.9K | 0.04% | 261 |
|
|
2017
Q4 | $69K | Hold |
575
| – | – | 0.02% | 346 |
|
|
2017
Q3 | $81K | Hold |
575
| – | – | 0.03% | 306 |
|
|
2017
Q2 | $70K | Sell |
575
-100
| -15% | -$12.2K | 0.02% | 294 |
|
|
2017
Q1 | $82K | Sell |
675
-150
| -18% | -$18.2K | 0.03% | 254 |
|
|
2016
Q4 | $101K | Hold |
825
| – | – | 0.04% | 224 |
|
|
2016
Q3 | $101K | Hold |
825
| – | – | 0.04% | 217 |
|
|
2016
Q2 | $96K | Hold |
825
| – | – | 0.05% | 239 |
|
|
2016
Q1 | $115K | Buy |
825
+100
| +14% | +$13.9K | 0.05% | 198 |
|
|
2015
Q4 | $138K | Hold |
725
| – | – | 0.07% | 177 |
|
|
2015
Q3 | $113K | Hold |
725
| – | – | 0.06% | 196 |
|
|
2015
Q2 | $131K | Hold |
725
| – | – | 0.06% | 196 |
|
|
2015
Q1 | $126K | Buy |
725
+50
| +7% | +$8.69K | 0.07% | 193 |
|
|
2014
Q4 | $125K | Buy |
+675
| New | +$125K | 0.09% | 181 |
|